Testing a flu shot for adults aged 60 and older
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study tests a new seasonal flu shot for people aged 60 and older. It aims to see if the vaccine is safe and how well it produces a protective immune response in older adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years of age or older.
- You have not had the flu or flu-like illness in the last 6 months.
- You have not had a flu shot in the last 12 months and are willing to avoid one during the study.
- You are free from serious chronic health problems (like uncontrolled high blood pressure, serious heart, liver, kidney disease, or active cancer).
- You have not used fever-reducing or pain medications within 3 days before vaccination.
- You are willing to attend all study visits and fill out a diary of how you feel.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an influenza (flu) vaccine in people aged 60 and above. It aims to see if the vaccine is safe and works well for older adults, who are at higher risk for flu complications.
This study tests a new flu vaccine to see how well it helps the body fight off the flu. It is for generally healthy adults aged 18 to 59 who have not had the flu recently.
This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.
This study looks at getting an influenza (flu) vaccine in adults age 75 and older. It may help doctors understand how to safely give flu shots to older adults.
This trial tests an experimental flu shot that includes an adjuvant (an ingredient that boosts the immune response). It aims to see if the shot is safe and how well it works in adults. Participation lasts for a few months and involves blood tests and a review of any side effects.
This trial tests new mRNA-based flu vaccines that may provide broader protection against different flu strains. Participants will receive the vaccine and be monitored for safety and their immune response.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.